Navigation Links
Dorsi-Flexion MPO

ProductsDorsi-Flexion MPO
Company Restorative Care of America
Item Dorsi-Flexion MPO
Features 
  • Provides adjustable static stretch of the plantar flexors, treating neuromuscular involvement conditions.
  • Medial/lateral straps attached to the sides of the brace allow the foot and ankle to be controlled, as needed, in the desired dorsi-flexion position prescribed.
  • Can be used as a night splint, inhibiting plantar flexion for the patient, stretching the posterior calf muscles essential for maintenance of dorsi-flexion range at the ankle.
  • Floating heel design eliminates pressure or friction on the heel and toes, enhancing blood circulation vital to the healing process.
  • Anti-rotation bar controls hip and leg rotation to maintain functional alignment.
  • Description The new Dorsi-Flexion MPO® by RCAI provides adjustable static stretch of the plantar flexors, treating neuromuscular involvement conditions such as diminished foot and ankle range of motion, pressure sores and hip rotation. Medial/lateral straps attached to the sides of the brace allow the foot and ankle to be controlled, as needed, in the desired dorsi-flexion position prescribed. The Dorsi-Flexion MPO can be used as a night splint, inhibiting plantar flexion for the patient, stretching the posterior calf muscles essential for maintenance of dorsi-flexion range at the ankle.

    The "floating heel" design of the brace eliminates pressure or friction on the heel and toes, enhancing blood circulation vital to the healing process. The anti-rotation bar controls hip and leg rotation to maintain functional alignment.

    Indicated for diminished foot and ankle range of motion, Achilles tendon rupture, cerebral palsy or when static progressive ankle positioning is recommended.
    Info Restorative Care of America
    Customer Service: (800) 627-1595
    Web site: http://www.rcai.com

    Related medicine products :

    1. Stability Cemented Stem
    ...
    Gentamicin Sulphate : Antibiotic that inhibits normal protein synthesis. USBio analysed. Autoclavable....
    Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....
    Gentamicin Reagent Solution (10 mg/ml) liquid...
    Medicine Products:
    (Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
    (Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
    (Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
    (Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
    (Date:10/12/2017)... Texas (PRWEB) , ... October 12, 2017 , ... ... and biologics manufacturer, has expanded its executive staff with the addition of industry ... In this role, Slott will develop the national distribution and sales network, direct ...
    Breaking Medicine News(10 mins):
    (Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
    (Date:9/19/2017)... a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed ...   ... Jim Bertolina, ... Tom Tefft ... medical device executive Josh Stopek , PhD, who has led R&D and business development ...
    (Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
    Breaking Medicine Technology: